The Devil on Trial: Netflix to release documentary on true crime case that inspired The Conjuring 3
Originally published at https://www.joblo.com/the-devil-on-trial-netflix/
CHICAGO, September 5, 2023 (Newswire.com) - Productive Edge, a leading healthcare-focused digital transformation consultancy, has announced the launch of Care AdvisorTM, an AI-powered productivity enhancement tool that integrates Generative AI with existing commercial software and custom solutions within the healthcare industry.
Productive Edge Care Advisor works alongside popular healthcare platforms and systems, assisting clinicians and administrators in daily tasks, such as the manual clinical review of Prior Authorizations submitted to health insurance companies by providers. It provides real-time intelligent assistance, enabling a new level of efficiency and precision to enhance creativity, productivity, and care coordination.
Care Advisor's Generative AI Models
Care Advisor offers a suite of Generative AI models tailored to critical healthcare workflows, leveraging advanced technologies like Google Cloud's Vertex AI and Microsoft's Azure OpenAI Service. The models are designed to streamline processes and enhance operations in areas including:
Raheel Retiwalla, Chief Strategy Officer of Productive Edge, commented on the launch, stating, "Care Advisor represents a transformative leap in healthcare administration. By leveraging Generative AI, we're not just streamlining processes; we're revolutionizing how providers and payers interact with patients. This technology has the potential to unlock $265 billion in annual savings, simplifying complex administrative burdens and enhancing patient experiences. At Productive Edge, we're committed to driving this innovation, laying the foundation for improved healthcare outcomes and cost savings."
For more information about Care Advisor and how it can revolutionize healthcare administration, visit Productive Edge's Care Advisor page to watch a video or request a demo.
Contact Information:
CHICAGO, September 5, 2023 (Newswire.com) - Clarity Clinic has added non-invasive Transcranial Magnetic Stimulation to its practice as another therapeutic option for those struggling with treatment-resistant depression, and is now accepting new patients at its Loop and Arlington Heights locations.
Major Depressive Disorder is a significant mental health condition in the US, one that has been exacerbated by the challenges of an ongoing pandemic. Clarity Clinic offers multiple treatment options for those struggling, including counseling and behavioral therapy as well as medication management. In some cases, however, anti-depressant pharmacological therapies are not effective. For those patients, TMS may be an effective option.
TMS, or Transcranial Magnetic Stimulation, is sometimes confused with Electroconvulsive Therapy (ECT), which is quite different. TMS is a non-invasive therapy that uses electromagnetic pulses to induce electrical activity in those parts of the brain that are underactive in depressed patients. The magnetic coils are placed against the patient's head during a session. The treatment has been shown effective in 49% of patients who have failed at least two prior medication courses. Additionally, it demonstrated a remission rate of 32% (Rush, et al., 2006). These statistics are markedly improved over additional medication courses.
TMS therapy has been cleared by the FDA since 2008. Side effects may include a mild, transient headache that abates over the course of the treatment. Patients can return to their normal activities immediately following a session. Insurance usually covers the treatment for those who qualify.
Clarity Clinic's CEO, Pavan Prasad, MD, said, "We are pleased to add TMS as another option for our patients with depression. This technology has the potential to bring relief to those who have not found it in other therapies."
Individuals seeking TMS treatment or looking for more information about Clarity Clinic's comprehensive mental health services can visit claritychi.com/TMS or contact (872) 277-8882 to schedule a consultation.
Contact Information:
READING, Pa., September 5, 2023 (Newswire.com) - Dr. Stephen Banco, a nationally recognized orthopedic spine surgeon, has achieved a groundbreaking milestone with the successful completion of the first-in-man spine surgery utilizing the innovative Waypoint GPS™ smart pedicle probe. This remarkable achievement marks a significant advancement in spinal surgery techniques, promising enhanced precision and patient outcomes.
The Waypoint GPS system, developed by Waypoint Orthopedics, Inc., intends to create a paradigm shift in spinal surgical navigation. By combining state-of-the-art visualization technology with standard instrumentation, the system aims to provide surgeons with increased accuracy and confidence during their cases. Dr. Banco's successful utilization of the technology underscores its potential to revolutionize the field of spine surgery.
During the surgery, Dr. Banco utilized the Waypoint GPS system to navigate the cannulation of 10 pedicles in a 5-level PLF. The system allowed Dr. Banco to identify optimal paths for his pedicle screws prior to tapping and execute the procedure with an unprecedented level of confidence without the use of fluoroscopic guidance. The real-time feedback provided by the system allowed Dr. Banco to carefully monitor and adjust every movement, ultimately leading to a 100% accuracy in screw placement, with zero pedicle breaches, as confirmed by x-ray and neuromonitoring.
"I am truly excited about the potential of the Waypoint GPS system," said Dr. Banco. "This technology has the capacity to redefine how we approach spine surgeries. Its accuracy and real-time feedback empower surgeons to make informed decisions during procedures, resulting in better patient outcomes and reduced recovery times."
The successful outcome of this pioneering surgery highlights the collaborative effort between Dr. Banco and the dedicated team at Waypoint Orthopedics, who have tirelessly worked to develop and refine the Waypoint GPS system. The achievement sets a new standard for precision in spine surgery in any surgical setting.
"We are immensely proud of Dr. Banco's accomplishment and the successful integration of our Waypoint GPS technology into clinical practice," stated Jeffrey F. O'Donnell, Jr., President and CEO of Waypoint Orthopedics. "This achievement is a testament to our commitment to innovation and improving patient care. We look forward to witnessing the continued impact of this technology on the lives of countless patients."
Waypoint Orthopedics is the first portfolio company of Runway Healthcare, LP, a MedTech accelerator fund. Runway Healthcare builds commercially ready opportunities for the medical device industry to acquire following regulatory approval.
The Waypoint GPS™ is FDA-cleared and indicated for use during pedicle screw pilot hole drilling to provide visual feedback to the surgeon of changes in color to the tissue at the tip of the probe that may indicate contact with soft tissues and possible vertebral cortex perforation. The Waypoint GPS is indicated for use in both open and percutaneous (MIS) procedures.
About Waypoint Orthopedics:
Waypoint Orthopedics, Inc. was founded to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics' product, the Waypoint GPS, uses proprietary color-sensing technology to inform the operator of the bone/tissue type change at the cutting edge of the awl. Waypoint Orthopedics' controlling stockholder is Runway Healthcare, LP - a MedTech accelerator fund.
Inquiries:
About Runway Healthcare, LP:
Runway Healthcare, LP is an early-stage MedTech accelerator. Runway Healthcare finances and manages the product development process of its portfolio companies. After navigating a portfolio company through the regulatory process, Runway Healthcare seeks to transition the portfolio company's ownership to a larger multi-national healthcare company for commercialization. Runway Healthcare is focused on early-stage technology in the Orthopedic, Cardiovascular, and Neurology sectors.
Inquiries:
Forward-Looking Statements:
This press release contains "forward-looking statements" concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company's expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.
Contact Information:
QUEEN CREEK, Ariz., September 5, 2023 (Newswire.com) - Most women going through perimenopause and postmenopause have one main complaint and that is weight gain, especially around their midsection. With the onset of weight gain, women are turning to popular GLP-1 agonist drugs like semaglutide to lose weight. What women need to understand is they cannot control what is lost: fat, muscle, water or a combination of the three. Women begin to lose three to eight percent of their muscle mass once they reach the age of 30 and this rate of decline increases the older they get, putting women at an even greater risk of losing more muscle by taking semaglutide.
What women need to do is focus on building muscle, not losing it, and putting the fear of getting "bulky" to rest — it simply won't happen. The mindset needs to shift to smart lifting sessions that include days with plyometrics to build strong bones, 20-minute HIIT/SIT sessions to improve insulin resistance and mobilize fat, consuming enough protein to support the body and training, and making sure women give themselves time to recover. Recovery is one of the most important gifts we can give to our body and that is why Lady Warrior created RecovHER™ roll-on.
Lady Warrior Announces Launch of New CBD Pain Relief Roll-on RecovHER™
RecovHER™ roll-on gel is a new CBD formula for muscle recovery. A proprietary blend, including 1500mg of pure hemp CBD extract, gives immediate relief and penetrates deep to work into sore muscles and joints to provide instant relief for aches and pains, fights inflammation, has an easy no-mess roll-on application, aids in muscle workout recovery, works into your muscles for long-term, and smells better than other brands.
Lady Warrior followers given early access to sample RecovHER™ recommend it for muscle recovery and pain relief. "I am amazed at how well RecovHER™ works and most importantly how fast it takes effect," said Megan L. "My legs were very sore from lifting and by the morning they were noticeably less sore."
RecovHER™ was formulated to both soothe and relieve tightness so users can still be active. "After stressing my hamstring I have been using RecovHER a few times a day and it's amazing," said Krista M. "I'm also using it on my notoriously tight shoulders and neck where I carry my stress, it really eases the tension.
RecovHER's proprietary blend and applicator provides quick relief. "RecovHER has 3x the amount of CBD of my current product so I found it provided faster and longer lasting relief of my muscle aches," said Erika Baka.
RecovHER's bottle was designed to be much easier to apply. "I really like RecovHER! Unlike another blue hued product on the market, this applied clear which I really like that it doesn't leave a discoloration on my skin," said Angie T.
For ordering, go to www.ladywarrior.shop.
Custom Service and Product Inquiries Contact: [email protected]
Disclaimer: These products are not intended to diagnose, treat, cure or prevent disease.
Contact Information:
HANOVER, Minn., September 5, 2023 (Newswire.com) - Unfiltered Discussions is a group of veterinary industry professionals discussing field-related topics in an unstructured format. Topics are decided right before recording, and episodes are uploaded immediately with no editing. Listeners get to hear true opinions and share thoughts in the comments.
Join Dr. Rob Trimble, Dr. Peter Weinstein, Kelly Baltzell, CEO of Beyond Indigo Pets, Sam Schopler, a veterinary student and veterinary technology consultant, Dr. Jules Benson, and Dr. Jessica Trimble each month as they discuss the latest industry buzz topic.
These conversations leverage varied perspectives of new and experienced minds in the industry to analyze trends, initiatives, and changes that impact established businesses navigating the veterinary space, and young veterinary professionals and pet owners.
Sam Schopler states, "Helping build a tech company in veterinary medicine and now attending my 4th year of vet school, I have had the unique opportunity to witness the industry react to recent changes from multiple angles. Unfiltered Discussions exist because we need to be able to speak honestly and with unbridled intrigue about the fast-paced developments taking place around veterinary medicine."
Each episode will delve into topics like change management, post-pandemic socio-economic shifts impacting veterinary spending, the influx of new practices making the hiring marketplace more competitive, and more.
According to Kelly Baltzell, "Unfiltered Discussions is a powerful space for people to explore concepts and ideas that go deeper than the conversations happening around specific topics in the veterinary field. Unfiltered Discussions dives deeper and ferrets out the underlying meaning behind opinions."
Unfiltered Discussions will release episodes monthly. You can listen to the first episode titled "Change Doesn't Have to Feel Like Torture" here.
Unfiltered Discussions brings together experts from every facet of the veterinary field to give real thoughts on real industry topics. The esteemed panel of hosts includes:
Dr. Rob Trimble: veterinarian and co-founder of Fuzzy Pet Health. He is the former Executive Director for the Veterinary Entrepreneurship Academy and is currently the VP of Harbor for Suveto.
Dr. Peter Weinstein: has been a veterinarian, a hospital owner, and president of Southern California VMA, California VMA, and Vet Partners. He has authored various publications and currently teaches business and finance at the Veterinary College of Western University of Health Sciences.
Kelly Baltzell: is the President and CEO of Beyond Indigo Pets marketing agency. Her articles and speaking engagements have been seen in MWI and around the U.S., Australia, New Zealand, Canada, and the UK. Kelly recently launched VetMarketingTalk: an online community for sharing marketing strategies and building connections between veterinary industry professionals.
Sam Schopler: As Director of Veterinary Alliances, Sam has helped grow PetDesk over the last eight years and is now in his last year of vet school at NCSU CVM. He is fascinated by how technology influences pet care and what that means for the future of veterinary medicine.
Dr. Jules Benson: is Nationwide's Chief Veterinary Officer and a strategic industry leader. He spent more than a decade in executive roles in the pet health insurance industry. He currently chairs the veterinary relations committee for the North American Pet Health Insurance Association (NAPHIA), and serves on the Executive Board of the Veterinary Innovation Council (VIC) board, and the MentorVet Advisory Board.
Dr. Jessica Trimble: has been practicing veterinary medicine since 2013. She has worked in mixed and small animal clinical practice, general practice, urgent care, and house call settings. She is currently the Chief Veterinary Officer of Anipanion and advises veterinary start-ups.
Contact Information:
LOS ANGELES, September 5, 2023 (Newswire.com) - Baxter of California, a men's grooming brand with a superior assortment of hair, skin and shaving essentials, introduces the Revitalizing Exfoliating Body Wash and expands their Aluminum-Free Deodorant collection with two new fragrances inspired by California landscapes. The addition of these products helps to nurture consumer needs and elevate their current grooming routines.
The Revitalizing Exfoliating Body Wash has a rich-lathering, hydrating formula for all skin types. This body wash is fit for everyday use and gently exfoliates the body to leave skin smooth, clean and fresh. This body wash has a subtle scent that is inspired by the iconic Exfoliating Body Bar. This wash is infused with ingredients including Pumice, which helps gently exfoliate dead skin, and a jojoba meal with Vitamins B and E to help maintain the skin's moisture and help exfoliate rough patches, boosting cell renewal.
"I'm excited for Baxter of California to be launching the Revitalizing Exfoliating Body Wash, especially with colder months creeping up on us. My skin tends to get dryer as the temperatures drop, and this body wash is just what I need to treat and prevent dry, flaky skin," says Jose Figueroa, Associate Brand Manager of Baxter of California. "Our team is always looking for new ways for our consumers to take their grooming routine up a notch and we think this body wash is the perfect addition to any grooming routine. I especially love that it has a subtle signature scent and is suited for all skin types, so a wide range of users can enjoy it."
Baxter of California is also expanding their cult-favorite Aluminum-Free and Alcohol-Free Deodorant with two new fragrances: Italian Lime and Pomegranate Essence, Cedarwood and Oakmoss Essence. These two new additions are inspired by other Baxter of California products that have these scents. This deodorant tackles odors by detoxifying and conditioning the skin with a clear, solid formula with tea tree and witch hazel. With the same consistent formula, this deodorant will now be available in the two new fragrances, along with the original scent, Citrus and Herbal Musk Essence.
"Our consumers love our Aluminum-Free and Alcohol-Free Deodorant formula because it really works; it does not stain clothing and works well for sensitive skin," says Jose Figueroa, Associate Brand Manager of Baxter of California. "This deodorant is a star at Baxter of California and we are so excited to now offer it to our customers in two new fragrance additions."
The Revitalizing Exfoliating Body Wash will be priced at $25 and the Aluminum-Free Alcohol Deodorant will be $22. You can shop these products on baxterofcalifornia.com and at the Baxter Finley Barber Shop starting Sept. 5, 2023.
###
ABOUT BAXTER OF CALIFORNIA
Since 1965, Baxter of California has been a pioneer in understanding and meeting personal care needs. Our curated range of hair, skin, shave, and body essentials and lifestyle products are all tested by master barbers at our award-winning Baxter Finley Barber & Shop in Los Angeles. Our products are designed for quality and versatility to provide consumers with everything they need to confidently be who they are.
EDITORIAL/MEDIA INQUIRIES: For all media inquiries, including sample requests, please contact Erin Johnson at [email protected].
HIGH-RES IMAGES: Linked HERE
Contact Information:
PARIS, September 5, 2023 (Newswire.com) - Tribun Health, a leading innovator in the field of digital pathology, is delighted to announce the completion of its Series B financing round, securing an investment of €15 million. This financing round is led by the Fonds Patient Autonome managed by Bpifrance, alongside several new investors, including Owkin and Vivalto Family, with whom the company has also signed commercial agreements, and the renewed support of its historic investor LBO France. Tribun Health, already twice awarded for the quality of its products and services by winning the prestigious "Best in KLAS Digital Pathology" global competition in 2022 and 2023, has been chosen to be part of the French Tech 2030 program, recognizing the company's remarkable achievements and confirming its potential to be at the forefront of innovation in digital healthcare.
The Series B funding round's success represents an important accomplishment for Tribun Health, further strengthening the company's financial position and opening new opportunities for growth in Europe and North America.
"We were impressed by both the potential of Tribun Health's software platform and the quality of its services. These strengths are supported by a strong management team and an innovative global vision that places the acquisition and valorization of healthcare data at the heart of tomorrow's diagnostics," said Jean-Briac Lesné, Investment Director at Bpifrance. "This stance solidified our decision to invest in the company to be part of their long-term success. I strongly believe that Tribun Health has the potential to transform the field of pathology and improve patient diagnosis and care," stated Sebastian Woynar, Managing Director - LBO France. "We are very excited to continue to be part of their remarkable journey."
In addition to the successful funding round, Tribun Health's selection as one of the participants in the highly selective French Tech 2030 program highlights the company's remarkable achievements and recognition as a leading player in the healthcare sector, particularly in the diagnostic landscape. Spearheaded by the French General Secretariat for Investment, the French Tech Mission, and Bpifrance, French Tech 2030 aims to provide tailored support to emerging innovators in strategic sectors. Tribun Health's participation in the program will grant access to extensive resources, collaboration opportunities with like-minded companies, engagement with private investors, and potential partnerships to further its technological advancements.
"We are honoured to be selected for the French Tech 2030 program, which recognizes our commitment to innovation and our impact on the health organization, providing solutions to improve the speed and the precision of cancer diagnosis," said Jean-François Pomerol, CEO of Tribun Health. "The provided support will enable us to push the boundaries of our AI-powered pathology platform, amplify our market reach, and make meaningful strides in the global healthcare landscape."
Rothschild acted as financial advisor to the company and Goodwin as legal advisor.
Contact Information:
Denzel Washington stars in his first ever threequel with The Equalizer 3 which is tracking to debut around $30 million.
This Labor Day weekend sees the release of just one new wide entry to theaters with the trilogy capper The Equalizer 3 starring Denzel Washington. The franchise, loosely based off the TV series of the same name that aired on CBS from 1985-1989, launched on September 26, 2014 where it opened with $34.1 million on its way to a $101.5 million domestic finish ($192.3 million worldwide). The sequel, 2018’s The Equalizer 2, would release in a prime summer slot of July 20 and open in first place with $36 million on its way to a $102 million domestic finish ($190.4 million worldwide). Those numbers are bolstered by the fact that director Antoine Fuqua keeps his budgets down with each film costing between $55- $75 million. Tracking for the film has it opening in the $30 million range and since that is about where the other two opened, that is what I will stick with for its 3-day take.
The film is currently seeing some decent reviews including an 8/10 from our own Chris Bumbray who enjoyed this third outing so much he hoped they would reconsider making this the final chapter in the lucrative franchise. Another factor that may help propel The Equalizer 3 to financial glory is its runtime. At 103 minutes it is the shortest film in the series by almost 20 minutes (Equalizer had a runtime of 132 minutes while Equalizer 2 carried a 121 minute run time). The film will also take over most of the PLF (Premium Large Format) screens this weekend from Gran Turismo and let us not forget that people enjoy a good piece of revenge cinema as just a few months ago we saw the excellent John Wick Chapter 4 pull in $187.1 million domestic with a $426.5 million worldwide gross. Equalizer 3 won’t hit those types of numbers, but it does show that when a series continues to put out quality, audiences will show up, and by most accounts Equalizer 3 is quality.
Speaking of Gran Turismo, many expect the based on a true story car racing tale to have a significant drop in its second weekend from its already lackluster opening. The thing is: the film carries a stellar 98% audience score with an A cinemascore, meaning word of mouth for this one should be strong. Having seen the film just last night (in IMAX) I can say that I thoroughly enjoyed this movie and think it deserved to do far better than it did in its opening weekend. The movie blended the visual style of the game with the real life story that inspired the film perfectly. Even though it carries a PG13 rating, I found this to be a pretty solid family film (although there is one F bomb for those who may not like such things.) But the story of a kid with a dream who is given the chance to achieve that dream is a tale as old as time, and in the hands of a skilled filmmaker like Neill Blomkamp and excellent performances by Archie Madekwe, Dijon Hounsou, Orlando Bloom and especially David Harbour (and even Spice Girl Geri Halliwell, aka Ginger Spice, puts in a solid performance as the lead character Jann’s mother. It was so good I didn’t even realize it was her until reading Chris Bumbray’s 8/10 review!) make the film a must see in theaters where you will get the full experience of the amazing race car sound design and mixing.
Gran Turismo actually did decent business during the week, of course that business wasn’t as good as Barbie which finished in first place on Monday and Tuesday. So it is likely that Barbie will continue her amazing run with a second place finish and around $13 million in receipts. The Margot Robbie/ Ryan Gosling led film became Warner Bros highest grossing film of all time this week, taking down Harry Potter and the Deathly Hallows Part 2, as it passed that films $1.342 worldwide gross. I wonder if Warner Bros is rethinking their plan to release the film to digital platforms on September 5 as it seems there is still a lot of gas in the tank for this one at the box office.
Fourth place should go to the DC film Blue Beetle with around $6-$7 million in receipts as the film struggles to hit the $100 million domestic mark, a mark I don’t believe it will achieve when all is said and done. At the end of the day, the movie just wasn’t very good and audiences are telling the studio as much by not going to see it. Even though James Gunn said that Blue Beetle will feature in his new DCU, I think he needs to cut ties with all previous characters and start fresh with his new Superman. There is already enough confusion among audiences in terms of the DCEU and the DCU, to where a new 100% fresh start with 2025’s Superman: Legacy is needed to get audiences back on one singular track going forward.
Rounding out the top five should be Oppenheimer with an additional $6-$7 million. What is amazing for this Christopher Nolan directed film is that even after it lost its big theater chain IMAX screens (the film has seen its run extended in its 70mm IMAX screens) it has maintained its momentum with small week to week drops meaning that it wasn’t just the larger than life screen spectacle that people have responded to, it is the film itself. As we enter the fall movie season where more and more awards contenders are released, you can expect Oppenheimer to continue to have a presence as Universal will certainly not want to lose momentum as this movie has a genuine shot at breaking (or at least tying) the record for most Academy Award nominations (which currently sits at 14 for Titanic, All About Eve and La La Land).
Out of the top five but worth noting is the expansion of the film Bottoms. The R rated sex comedy opened last week on just ten screens where it pulled in a stellar $461,052, which equates to a $46,105 per screen average. The film is getting an expansion this week and depending on word of mouth could potentially hit the top ten.
Do you plan on hitting up theaters this weekend? If so, let us know in the comments what you plan on seeing and don’t forget to check back on Saturday when we have a brief update on where the box office numbers are heading.
TOP FIVE PREDICTIONS
Originally published at https://www.joblo.com/box-office-predictions-denzel-is-back-in-the-equalizer-3/
All Fun and Games exclusive clip plays a deadly game of hide and seek
Originally published at https://www.joblo.com/all-fun-and-games-exclusive-clip-plays-a-deadly-game-of-hide-and-seek/
